InvestorsHub Logo
Followers 18
Posts 1459
Boards Moderated 0
Alias Born 11/01/2018

Re: None

Monday, 01/30/2023 12:17:02 PM

Monday, January 30, 2023 12:17:02 PM

Post# of 462057
Approval For Anavex's Blarcamesine Looks Inevitable After Biogen's Leqembi Approved

New Efficacy News
The Blarcamesine Phase 2b/3 results are more impressive than the Leqembi Phase 3 results. The cognitive test results clearly favor Blarcamesine.

https://seekingalpha.com/article/4573554-approval-for-anavex-blarcamesine-looks-inevitable?mailingid=30400571&messageid=2800&serial=30400571.2525&utm_campaign=rta-stock-article&utm_medium=email&utm_source=seeking_alpha&utm_term=30400571.2525
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News